Trials / Completed
CompletedNCT02814240
Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) Imaging
Hepatic Steatosis and Pituitary Gland Failure, Evaluation by NMR Imaging
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigator put forward the hypothesis that liver fat mass in patients with pituitary gland failure is greater than that in a control population. Failure of the anterior pituitary and more particularly impaired production of growth hormone (GH) could be the principal mechanism responsible for increased liver fat mass in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NMR | |
| BIOLOGICAL | Blood samples | |
| OTHER | fibroscan |
Timeline
- Start date
- 2015-03-16
- Primary completion
- 2015-10-10
- Completion
- 2015-10-10
- First posted
- 2016-06-27
- Last updated
- 2024-02-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02814240. Inclusion in this directory is not an endorsement.